Arousal Threshold in the Pathogenesis of Obstructive Sleep Apnea

阻塞性睡眠呼吸暂停发病机制中的唤醒阈值

基本信息

项目摘要

Obstructive sleep apnea (OSA) is a highly prevalent condition with major neurocognitive and cardiovascular sequelae. Despite its recognized consequences, the treatment of this condition remains unacceptable as the existing therapies are poorly tolerated and/or have highly variable efficacy. The role of the arousal threshold has received minimal attention in the OSA literature; despite recent recognition that the propensity to wake up from sleep may have a major pathophysiological role is OSA. The accumulation of respiratory stimuli during sleep can activate upper ainway muscles to preserve pharyngeal patency, but can only do so if sufficient time is available for 002 and negative pressure to develop. That is, premature awakening could lead to recurrent arousals and prevent the stabilization of pharyngeal patency during sleep. The present application will study differences in arousal threshold between OSA and matched controls (Aim 1), and the reversibility of abnormalities in OSA with CPAP therapy (Aim 2). The role of non-myorelaxant hypnotic therapy will also be assessed from standpoint of the effects on upper ainway mechanics and control (Aim 3) and therapeutic effects on short-term clinical outcome (Aim 4). Our research will interact heavily with all of the other Projects within this PPG by providing clinical relevance to the basic research regarding the role of the parabrachial complex on arousal from sleep. In addition, the proposed rodent experiments by our collaborators will provide mechanistic insights into the arousal response which would involve studies neither feasible nor ethical in humans. Project 2 will therefore define the potential role of the arousal threshold in OSA pathogenesis and its viability as a therapeutic target in OSA, at least for a subgroup of patients.
阻塞性睡眠呼吸暂停(OSA)是一种高度流行的疾病,主要与神经认知和心血管疾病有关。 后遗症尽管其后果得到承认,但对这种情况的治疗仍然是不可接受的, 现有的疗法耐受性差和/或具有高度可变的功效。唤醒的作用 阈值在OSA文献中受到的关注最少;尽管最近认识到, 从睡眠中醒来可能有一个主要的病理生理作用是阻塞性睡眠呼吸暂停综合征。呼吸道的积累 睡眠时的刺激可以激活上气道肌肉,以保持咽部的通畅,但只有在以下情况下才能这样做, 有足够的时间可用于产生002和负压。也就是说,过早的觉醒可能 导致反复觉醒并阻止睡眠期间咽部开放的稳定。本 应用程序将研究OSA和匹配对照之间的唤醒阈值差异(目标1), CPAP治疗OSA异常的可逆性(目的2)。非肌松催眠药的作用 还将从对上气道力学和控制的影响的角度评估治疗(目标3) 以及对短期临床结果的治疗效果(目的4)。我们的研究将与所有 本PPG中的其他项目,通过提供与基础研究的临床相关性, 臂旁复合体对睡眠觉醒的影响此外,我们建议的啮齿动物实验 合作者将提供对唤醒反应的机械见解,这将涉及研究, 在人类身上是可行的也是不道德的。因此,项目2将定义唤醒阈值在以下方面的潜在作用: OSA发病机制及其作为OSA治疗靶点的可行性,至少对于一个亚组的患者。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Atul Malhotra其他文献

Atul Malhotra的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Atul Malhotra', 18)}}的其他基金

The cardiovascular consequences of sleep apnea plus COPD (Overlap syndrome)
睡眠呼吸暂停加慢性阻塞性肺病(重叠综合征)对心血管的影响
  • 批准号:
    10733384
  • 财政年份:
    2023
  • 资助金额:
    $ 30.08万
  • 项目类别:
VentNet: A Real-Time Multimodal Data Integration Model for Prediction of Respiratory Failure in Patients with COVID-19
VentNet:用于预测 COVID-19 患者呼吸衰竭的实时多模式数据集成模型
  • 批准号:
    10367298
  • 财政年份:
    2022
  • 资助金额:
    $ 30.08万
  • 项目类别:
VentNet: A Real-Time Multimodal Data Integration Model for Prediction of Respiratory Failure in Patients with COVID-19
VentNet:用于预测 COVID-19 患者呼吸衰竭的实时多模式数据集成模型
  • 批准号:
    10573201
  • 财政年份:
    2022
  • 资助金额:
    $ 30.08万
  • 项目类别:
Sleep Apnea Endophenotypes: One Size Does Not Fit All
睡眠呼吸暂停内表型:一种方法并不适用于所有情况
  • 批准号:
    10084644
  • 财政年份:
    2021
  • 资助金额:
    $ 30.08万
  • 项目类别:
Sleep Apnea Endophenotypes: One Size Does Not Fit All
睡眠呼吸暂停内表型:一种方法并不适用于所有情况
  • 批准号:
    10404911
  • 财政年份:
    2021
  • 资助金额:
    $ 30.08万
  • 项目类别:
Sleep Apnea Endophenotypes: One Size Does Not Fit All
睡眠呼吸暂停内表型:一种方法并不适用于所有情况
  • 批准号:
    10686814
  • 财政年份:
    2021
  • 资助金额:
    $ 30.08万
  • 项目类别:
Underlying mechanisms of obesity-induced obstructive sleep apnea
肥胖引起的阻塞性睡眠呼吸暂停的潜在机制
  • 批准号:
    10404650
  • 财政年份:
    2020
  • 资助金额:
    $ 30.08万
  • 项目类别:
Is Obstructive Sleep Apnea Important in the Development of Alzheimer's Disease
阻塞性睡眠呼吸暂停对阿尔茨海默病的发展很重要吗
  • 批准号:
    9974144
  • 财政年份:
    2020
  • 资助金额:
    $ 30.08万
  • 项目类别:
Underlying mechanisms of obesity-induced obstructive sleep apnea
肥胖引起的阻塞性睡眠呼吸暂停的潜在机制
  • 批准号:
    10636633
  • 财政年份:
    2020
  • 资助金额:
    $ 30.08万
  • 项目类别:
Is Obstructive Sleep Apnea Important in the Development of Alzheimer's Disease
阻塞性睡眠呼吸暂停对阿尔茨海默病的发展很重要吗
  • 批准号:
    10615709
  • 财政年份:
    2020
  • 资助金额:
    $ 30.08万
  • 项目类别:

相似海外基金

An innovative, AI-driven prehabilitation platform that increases adherence, enhances post-treatment outcomes by at least 50%, and provides cost savings of 95%.
%20创新、%20AI驱动%20康复%20平台%20%20增加%20依从性、%20增强%20治疗后%20结果%20by%20at%20至少%2050%、%20和%20提供%20成本%20节省%20of%2095%
  • 批准号:
    10057526
  • 财政年份:
    2023
  • 资助金额:
    $ 30.08万
  • 项目类别:
    Grant for R&D
Improving Repositioning Adherence in Home Care: Supporting Pressure Injury Care and Prevention
提高家庭护理中的重新定位依从性:支持压力损伤护理和预防
  • 批准号:
    490105
  • 财政年份:
    2023
  • 资助金额:
    $ 30.08万
  • 项目类别:
    Operating Grants
I-Corps: Medication Adherence System
I-Corps:药物依从性系统
  • 批准号:
    2325465
  • 财政年份:
    2023
  • 资助金额:
    $ 30.08万
  • 项目类别:
    Standard Grant
Unintrusive Pediatric Logging Orthotic Adherence Device: UPLOAD
非侵入式儿科记录矫形器粘附装置:上传
  • 批准号:
    10821172
  • 财政年份:
    2023
  • 资助金额:
    $ 30.08万
  • 项目类别:
Nuestro Sueno: Cultural Adaptation of a Couples Intervention to Improve PAP Adherence and Sleep Health Among Latino Couples with Implications for Alzheimer’s Disease Risk
Nuestro Sueno:夫妻干预措施的文化适应,以改善拉丁裔夫妇的 PAP 依从性和睡眠健康,对阿尔茨海默病风险产生影响
  • 批准号:
    10766947
  • 财政年份:
    2023
  • 资助金额:
    $ 30.08万
  • 项目类别:
CO-LEADER: Intervention to Improve Patient-Provider Communication and Medication Adherence among Patients with Systemic Lupus Erythematosus
共同领导者:改善系统性红斑狼疮患者的医患沟通和药物依从性的干预措施
  • 批准号:
    10772887
  • 财政年份:
    2023
  • 资助金额:
    $ 30.08万
  • 项目类别:
Pharmacy-led Transitions of Care Intervention to Address System-Level Barriers and Improve Medication Adherence in Socioeconomically Disadvantaged Populations
药房主导的护理干预转型,以解决系统层面的障碍并提高社会经济弱势群体的药物依从性
  • 批准号:
    10594350
  • 财政年份:
    2023
  • 资助金额:
    $ 30.08万
  • 项目类别:
Antiretroviral therapy adherence and exploratory proteomics in virally suppressed people with HIV and stroke
病毒抑制的艾滋病毒和中风患者的抗逆转录病毒治疗依从性和探索性蛋白质组学
  • 批准号:
    10748465
  • 财政年份:
    2023
  • 资助金额:
    $ 30.08万
  • 项目类别:
Improving medication adherence and disease control for patients with multimorbidity: the role of price transparency tools
提高多病患者的药物依从性和疾病控制:价格透明度工具的作用
  • 批准号:
    10591441
  • 财政年份:
    2023
  • 资助金额:
    $ 30.08万
  • 项目类别:
Development and implementation of peer-facilitated decision-making and referral support to increase uptake and adherence to HIV pre-exposure prophylaxis in African Caribbean and Black communities in Ontario
制定和实施同行协助决策和转介支持,以提高非洲加勒比地区和安大略省黑人社区对艾滋病毒暴露前预防的接受和依从性
  • 批准号:
    491109
  • 财政年份:
    2023
  • 资助金额:
    $ 30.08万
  • 项目类别:
    Fellowship Programs
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了